{
  "context": {
    "rules": [
      "Rule1: A Platform distributes a Drug or a Platform markets a Drug.",
      "Rule2: If a Platform markets a Drug, then either the Region imports the Drug or it is not true that the Region exports the Drug.",
      "Rule3: Whenever a Region regulates a Platform, then if the Platform distributes a Drug, the outcome is that either the Region imports the Drug or the Region does not export the Drug.",
      "Rule4: Under the condition that a Region licenses a Platform, if the Platform distributes a Drug, then either the Region imports the Drug or the Region does not export the Drug.",
      "Rule5: If a Platform manufactures a Drug, then the Platform operates an ElectronicDevice.",
      "Rule6: Provided that a Platform packages a Drug, the Platform operates an ElectronicDevice.",
      "Rule7: A Platform contaminates a Drug, or the Platform manufactures a Drug, or the Platform packages a Drug.",
      "Rule8: If a Platform quarantines a Drug, then it is not the case that the Platform contaminates the Drug.",
      "Rule9: A Platform quarantines a Drug or a Platform recalls a Drug.",
      "Rule10: Supposing that a Platform requires an ElectronicDevice, then the ElectronicDevice functions at the Platform.",
      "Rule11: Either a Platform requires an ElectronicDevice, or if the Platform does not operate the ElectronicDevice, then the Region does not produce the Drug.",
      "Rule12: Provided that a Platform recalls a Drug, the Platform destroys the Drug.",
      "Rule13: Whenever a Drug is sterile at a Platform, then the Drug is purified at the Platform.",
      "Rule14: Under the condition that a Drug is purified at a Platform, the Platform does not reprocess the Drug.",
      "Rule15: Provided that a Platform stores a Drug, the Platform operates an ElectronicDevice.",
      "Rule16: A Platform stores a Drug or a Platform transports a Drug.",
      "Rule17: When a Platform delivers a Drug, the Platform operates an ElectronicDevice.",
      "Rule18: Provided that a Drug degrades at a Platform, the Drug deteriorates at the Platform.",
      "Rule19: Under the condition that a Region approves a Drug, the Platform does not require an ElectronicDevice.",
      "Rule20: Either a Region approves a Drug or a Platform is compliant with an ElectronicDevice.",
      "Rule21: Whenever a Drug deteriorates at a Platform, the Drug spoils at the Platform.",
      "Rule22: Provided that a Drug spoils at a Platform, the Drug expires at the Platform.",
      "Rule23: A Drug is stable at a Platform or a Platform operates an ElectronicDevice.",
      "Rule24: If a Platform tests the stability of a Drug, then the Drug is unstable at the Platform.",
      "Rule25: Under the condition that a Platform analyzes the shelf life of a Drug, the Drug is not stable at the Platform.",
      "Rule26: Supposing that a Platform conducts clinical trials on a Drug, then the Platform tests the stability of the Drug.",
      "Rule27: If a Platform studies the efficacy of a Drug, then the Platform analyzes the shelf life of the Drug.",
      "Rule28: Provided that a Platform reviews data on a Drug, the Platform conducts clinical trials on the Drug.",
      "Rule29: A Platform reviews data on a Drug or a Platform verifies results for a Drug.",
      "Rule30: Under the condition that a Platform verifies results for a Drug, the Platform studies the efficacy of the Drug.",
      "Rule31: Provided that a Platform submits a report for an ElectronicDevice, the Region approves the report from the Platform.",
      "Rule32: If a Platform submits a report for an ElectronicDevice, then the Region rejects the report from the Platform.",
      "Rule33: A Platform submits a report for an ElectronicDevice, or the Platform maintains records for the ElectronicDevice, or the Platform does not pass audit for the ElectronicDevice.",
      "Rule34: Supposing that a Region rejects a report from a Platform, then the Region does not approve the report from the Platform.",
      "Rule35: Provided that a Platform repairs an ElectronicDevice, then the ElectronicDevice does not malfunction at the Platform.",
      "Rule36: Under the condition that a Platform is certified for an ElectronicDevice, the Platform does not require the ElectronicDevice.",
      "Rule37: If a Platform replaces an ElectronicDevice, then the ElectronicDevice does not malfunction at the Platform.",
      "Rule38: Whenever a Platform schedules maintenance for an ElectronicDevice, the Platform services the ElectronicDevice.",
      "Rule39: A Platform schedules maintenance for an ElectronicDevice or a Platform performs maintenance on an ElectronicDevice.",
      "Rule40: Provided that a Platform performs maintenance on an ElectronicDevice, then the Platform repairs the ElectronicDevice or the Platform replaces the ElectronicDevice.",
      "Rule41: Supposing that a Region inspects a Platform, then the Region regulates the Platform or the Region licenses the Platform.",
      "Rule42: A Region inspects a Platform or a Region audits a Platform.",
      "Rule43: Under the condition that a Platform modifies the formula of a Drug, the Platform improves the efficacy of the Drug.",
      "Rule44: A Platform modifies the formula of a Drug, or if it is not the case that if the Region audits the Platform then the Region regulates the Platform or licenses the Platform, then the Region does not sanction the Platform.",
      "Rule45: Whenever a Region monitors a Drug, then if the Platform is compliant with an ElectronicDevice, the Platform is certified for the ElectronicDevice.",
      "Rule46: A Region monitors a Drug or a Region tests a Drug.",
      "Rule47: Under the condition that a Platform develops a new Drug, the Platform patents the new Drug.",
      "Rule48: A Platform develops a new Drug, or the Platform enhances the delivery of a Drug, or if the Platform modifies the formula of the Drug, then the Platform does not improve the efficacy of the Drug.",
      "Rule49: Provided that a Region investigates a complaint about a Platform, then the Platform has not resumed operations for the Drug.",
      "Rule50: A Region investigates a complaint about a Platform or a Region reviews a complaint about a Platform.",
      "Rule51: If a Region resolves an issue with a Platform, then if the Region reviews a complaint about the Platform, the Platform has not resumed operations for the Drug.",
      "Rule52: A Region resolves an issue with a Platform or a Region implements changes at the Platform.",
      "Rule53: Whenever a Region implements changes at a Platform, the Region updates procedures at the Platform.",
      "Rule54: If a Region prevents recurrence at a Platform, then if the Region reviews a complaint about the Platform, the Platform has not resumed operations for the Drug.",
      "Rule55: Under the condition that a Region updates procedures at a Platform, the Region trains personnel at the Platform.",
      "Rule56: If a Region trains personnel at a Platform, then the Region prevents recurrence at the Platform.",
      "Rule57: Supposing that a Platform monitors a shipment of a Drug, the Platform verifies the delivery of the Drug.",
      "Rule58: A Platform monitors a shipment of a Drug or a Platform tracks a shipment of a Drug.",
      "Rule59: If a Platform tracks a shipment of a Drug, then if it is not the case that if the Platform transports the Drug then the Platform delivers the Drug, the Drug expires at the Platform.",
      "Rule60: Under the condition that a Platform verifies the delivery of a Drug, then if it is not the case that if the Platform transports the Drug then the Platform delivers the Drug, the Drug expires at the Platform.",
      "Rule61: A Platform controls the temperature for a Drug or a Platform maintains humidity for a Drug.",
      "Rule62: Whenever a Platform maintains humidity for a Drug, then if the Platform transports the Drug, the Platform delivers the Drug.",
      "Rule63: A Drug deviates from specification at a Platform or the Drug does not exceed tolerance at the Platform.",
      "Rule64: Supposing that a Drug meets standards at a Platform, the Drug does not deviate from specification at the Platform.",
      "Rule65: If a Drug fails validation at a Platform, then the Drug passes validation at the Platform.",
      "Rule66: A Drug fails validation at a Platform or a Drug meets standards at the Platform.",
      "Rule67: Under the condition that a Platform documents the process for a Drug, the Platform revalidates the Drug.",
      "Rule68: A Platform documents the process for a Drug or a Platform revises the protocol for a Drug.",
      "Rule69: Provided that a Platform revises the protocol for a Drug, the Drug does not pass validation at the Platform.",
      "Rule70: A Platform complies with regulations for a Drug, or the Drug is unstable at the Platform, or the Drug is not stable at the Platform.",
      "Rule71: If a Region applies for approval of a Platform, then the Region issues a certificate to the Platform.",
      "Rule72: A Region applies for approval of a Platform or a Region seeks a license for a Platform.",
      "Rule73: Provided that a Region seeks a license for a Platform, the Platform does not comply with regulations for the Drug.",
      "Rule74: Supposing that a Region grants approval to a Platform, the Platform does not comply with regulations for the Drug.",
      "Rule75: If a Region issues a certificate to a Platform, then the Region grants approval to the Platform.",
      "Rule76: In case it is not the case that a Region regulates a Platform or licenses a Platform, then the Region penalizes the Platform.",
      "Rule77: Provided that it is not the case that a Platform manufactures a Drug or packages a Drug, the Platform has suspended operations for the Drug.",
      "Rule78: If it is not the case that if the Platform destroys the Drug then the Platform does not contaminate the Drug, then the Platform reprocesses the Drug.",
      "Rule79: Supposing that it is not the case that if the Platform transports the Drug then the Platform delivers the Drug, the Drug degrades at the Platform.",
      "Rule80: Provided that it is not the case that if the Platform calibrates the ElectronicDevice then if the Platform requires the ElectronicDevice the ElectronicDevice does not function at the Platform, then the ElectronicDevice malfunctions at the Platform.",
      "Rule81: Under the condition that it is not the case that if the Region audits the Platform then the Region regulates the Platform or licenses the Platform, then the Region sanctions the Platform.",
      "Rule82: Whenever it is not the case that if the Region tests the Drug then if the Platform is compliant with the ElectronicDevice the Platform is certified for the ElectronicDevice, then the Region violates the Drug.",
      "Rule83: Supposing that it is not the case that if the Platform controls the temperature for the Drug then if the Platform transports the Drug the Platform delivers the Drug, then the Drug exceeds tolerance at the Platform.",
      "Rule84: If it is not the case that if it is not the case that the Platform manufactures the Drug or packages the Drug then the Platform does not have suspended operations for the Drug, then the Platform has resumed operations for the Drug.",
      "Rule85: Under the condition that it is not the case that if it is not the case that the Platform is compliant with the ElectronicDevice then the Platform is certified for the ElectronicDevice then the Platform fails compliance for the ElectronicDevice, then the Platform passes audit for the ElectronicDevice.",
      "Rule86: Provided that the Platform does not operate the ElectronicDevice, the Region produces the Drug.",
      "Rule87: If the Platform does not operate the ElectronicDevice, then the Region exports the Drug."
    ],
    "facts": [
      "Fact1: A Drug is sterile at a Platform.",
      "Fact2: A Platform calibrates an ElectronicDevice.",
      "Fact3: It is not the case that a Region imports a Drug.",
      "Fact4: A Region does not penalize a Platform.",
      "Fact5: A Drug does not expire at a Platform.",
      "Fact6: A Drug is not unstable at a Platform.",
      "Fact7: A Platform does not fail compliance for an ElectronicDevice.",
      "Fact8: A Platform does not maintain records for an ElectronicDevice.",
      "Fact9: A Platform does not service an ElectronicDevice.",
      "Fact10: A Platform does not enhance the delivery of a Drug.",
      "Fact11: A Platform does not patent a new Drug.",
      "Fact12: A Region does not violate a Drug.",
      "Fact13: A Platform does not revalidate a Drug."
    ]
  },
  "question": "A Platform operates an ElectronicDevice."
}